No CrossRef data available.
Article contents
Preliminay study for the Italian validation of the screen for cognitive impairment in psychiatry (SCIP)
Published online by Cambridge University Press: 23 March 2020
Abstract
The screen for cognitive impairment in psychiatry (SCIP) is a brief, accessible scale designed for detecting cognitive deficits in psychiatric disorders.
The objective of this study is to test the SCIP's validity as a cognitive test by comparison with standard neuropsychological scale using the Pearson's correlation.
Aims Test the convergent and discriminant validity of the SCIP within the Italian SCIP validation project.
Patients between 18 and 65 years who are in a stable phase of the disease, diagnosed with schizophrenia, schizoaffective disorder or bipolar I disorder were enrolled in this study, from the community mental health department of Ferrara.
The tests were administered to 110 patients (mean age: 45 ± 11,4) and to 86 controls (mean age: 35 ± 12,6) of both sex. SCIP presents high correlation with the R-BANS total score (P < 0.01) and the subscales (verbal learning test-immediate, working memory, verbal fluency test, verbal learning test-delayed, processing speed test, P < 0.01). There are significant differences (P < 0.01) in all SCIP dimensions between patient and control group (Table 1).
Our analysis confirm the results of the English, French and Spanish version of the SCIP regarding convergent and discriminant validity. The SCIP represents a valid, simple and brief screening tool for the cognitive evaluation of patients with schizophrenia-spectrum disorders.
The authors have not supplied their declaration of competing interest.
- Type
- e-Poster Walk: Ethics and psychiatry/Philosophy and psychiatry/Others–Part 1
- Information
- European Psychiatry , Volume 41 , Issue S1: Abstract of the 25th European Congress of Psychiatry , April 2017 , pp. S331 - S332
- Copyright
- Copyright © European Psychiatric Association 2017
Comments
No Comments have been published for this article.